| Literature DB >> 27450437 |
Yongmei Zhao1, Yalan Fang2, Jincheng Li2, Yunxia Duan2, Haiping Zhao2, Li Gao3, Yumin Luo4.
Abstract
Ischemia/reperfusion (I/R) involves a cascade of reactions which ultimately lead to neuronal apoptosis or death. Inflammation plays an important role in this cascade. Chrysophanol (CHR), a purified active constituent from rhubarb, possesses many biological activities including anti-inflammation. The present study investigated the long-term neuroprotective effects of CHR on focal ischemic brain injury and the potential mechanism. Mice were subjected to 45-min middle cerebral artery occlusion and received either vehicle or CHR at 0.1, 1 or 10mg/kg for 14days after reperfusion. Neurological function, survival rate, brain tissue loss, expression of pro-inflammatory factors tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β) and nuclear factor-kappa B p65 (NF-κB p65) were then assessed. The results showed that treatment with CHR led to improved survival rate and reduced brain tissue loss compared with vehicle-treated mice, accompanied by improved neurological assessment and motor function, which were sustained for 14days after I/R. I/R-induced expression of TNF-α, IL-1β and NF-κB p65 in neurons was markedly reduced in CHR-treated mice. These results indicate that CHR markedly attenuates brain injury after focal I/R, which is attributed at least in part to its anti-inflammatory actions.Entities:
Keywords: Cerebral ischemia; Chrysophanol; Inflammation; Middle cerebral artery occlusion; Nuclear factor-kappa B
Mesh:
Substances:
Year: 2016 PMID: 27450437 DOI: 10.1016/j.neulet.2016.07.036
Source DB: PubMed Journal: Neurosci Lett ISSN: 0304-3940 Impact factor: 3.046